Arginine salts of obicetrapib

TW202635647APending Publication Date: 2026-09-01NEWAMSTERDAM PHARMA BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114151720
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-07-29
Filing Date
2025-12-29
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001075064_001
    Figure TWG2TA001075064_001
  • Figure TWG2TA001075064_002
    Figure TWG2TA001075064_002
  • Figure TWG2TA001075064_003
    Figure TWG2TA001075064_003
Patent Text Reader

Abstract

Obicetrapib L-arginine salts and processes for preparing such obicetrapib L-arginine salts are provided for herein as well as obicetrapib L-arginine salts made by such processes. Further provided are pharmaceutical compositions comprising such obicetrapib L-arginine salts and one or more pharmaceutically acceptable excipients. In addition, methods of treating diseases with pharmaceutical compositions comprising such obicetrapib L-arginine salts are provided.
Need to check novelty before this filing date? Find Prior Art